16.61USD-0.78%Mkt Cap: 738.36M USDP/E: —Last update: 2026-05-22
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to iden…
Industry Peers
Drug Manufacturers - Specialty & Genericloading…
Indicators:|
Key Statistics
Company
Market Cap738.36M USD
Enterprise Value364.98M USD
Revenue (TTM)10.32M USD
Gross Profit-72.95M USD
Net Income (TTM)-80.61M USD
Revenue/Share0.2740 USD
Last Price16.61 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees60
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.18
PEG—
EV/EBITDA-3.60
EV/Revenue35.38
P/S72.13
P/B1.96
EPS (TTM)-2.40
EPS (Forward)-2.71
52W Range
3.79063% of range24.00
52W High24.00 USD
52W Low3.790 USD
Profitability
Gross Margin0.00%
Oper. Margin-915.40%
EBITDA Margin0.00%
Profit Margin-896.11%
ROE-29.63%
ROA-27.33%
Growth
Revenue Growth91.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-81.63M USD
CapEx (TTM)719.00K USD
FCF Margin-565.51%
FCF Yield-7.90%
Net Debt-379.16M USD
Net Debt/EBITDA3.74
Balance Sheet
Debt/Equity0.02
Current Ratio24.76
Quick Ratio24.38
Book Value/Sh8.541 USD
Cash/Share8.620 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Target (Mean)51.43 USD
Target Range23.00 USD – 73.00 USD
# Analysts7
Ownership
Shares Out.44.45M
Float33.69M
Insiders2.44%
Institutions81.47%
Short Interest
Short Ratio4.4d
Short % Float4.80%
Short % Out.4.24%
Shares Short1.88M
Short (prev mo.)1.56M
Technical
SMA 5017.73 (-6.3%)
SMA 20012.79 (+29.9%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)398.03K
Avg Vol (10d)398.76K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—